Delivery Order SPE2D021DA002-SPE2D325F256M
- Not listed
- The Defense Logistics Agency (DLA), acting under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 2, 2025, has a ceiling value of $1,916.75 and is scheduled for completion by October 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance by the vendor from its location in Park Ridge, Illinois. DMS Pharmaceutical...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector units (quantity 2). This firm fixed-price delivery order, valued at $1,742.50, was issued on October 2, 2025, with an ultimate completion date of October 3, 2025, and does not include a set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector kits (two-pack) with a contract ceiling value of $1,045.50. The award, issued on June 27, 2025, with an ultimate completion date of July 2, 2025, was made without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 29, 2025, for epinephrine 0.3 mg auto-injector supplies (2-pack) valued at $1,219.75. This firm fixed-price delivery order, issued without set-aside designation, supports the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 30, 2025. The award is issued under DMS Pharmaceutical Group's...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,921.25, is for the delivery of epinephrine 0.3 mg auto-injectors to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award, issued on September 5, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Park Ridge location. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,983.53 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and performance to be fulfilled in...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $2,644.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the delivery of epinephrine auto-injectors with a period of performance through May 3, 2024. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,395.15 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F256MDelivery Order
The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for Epinephrine 0.3 mg auto-injector units (2-pack configuration) with a ceiling value of $1,394.00. The award, issued on July 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This delivery order was issued without set-aside designation and is being fulfilled at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, serves as the prime contractor. The company holds a significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program valued at $499,999,999 through November 2026, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities. This specific delivery order for epinephrine auto-injectors aligns with DMS Pharmaceutical Group's core business of supplying medications, biologics, and medical consumables directly to Department of Defense healthcare sites nationwide. The company has demonstrated consistent success competing for federal pharmaceutical contracts leveraging its small business status.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/23/25 |